Reidar Fossmark相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H+/K+ATPase Beta Subunit Knockout Mice

在 H+/K+ATPase β 亚基敲除小鼠中，胃泌素受体拮抗剂可预防胃体粘膜增生和神经内分泌细胞增生，但不能预防解痉多肽表达化生

期刊:International Journal of Molecular Sciences

影响因子:0.7

doi:10.3390/ijms21030927

Kristin Matre Aasarød, Helge Lyder Waldum, Astrid Kamilla Stunes, Arne Kristian Sandvik, Arnar Flatberg, Patricia Mjønes, Unni Syversen, Ingunn Bakke, Reidar Fossmark

发表日期：2020

文献求助收藏

Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells

胆囊收缩素 B 受体在胃肿瘤细胞中的表达

期刊:Hormones & Cancer

doi:10.1007/s12672-017-0311-8

Patricia Mjønes, Ivar S Nordrum, Øystein Sørdal, Liv Sagatun, Reidar Fossmark, Arne Sandvik, Helge L Waldum

发表日期：2018

文献求助收藏

The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival

细胞保护蛋白丛集素在高胃泌素血症啮齿动物泌酸癌前病变模型中过度表达，并促进胃癌细胞存活

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0184514

Pål Vange, Torunn Bruland, Berit Doseth, Reidar Fossmark, Mirta M L Sousa, Vidar Beisvag, Øystein Sørdal, Gunnar Qvigstad, Helge L Waldum, Arne K Sandvik, Ingunn Bakke

发表日期：2017

文献求助收藏

ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H(+) K(+) ATPase alpha subunit

胃 H(+) K(+) ATPase α 亚基失活突变纯合子患者的 ECL 细胞类癌和癌

影响因子:2.2

doi:10.1111/apm.12546

Reidar Fossmark, Oriol Calvete, Patricia Mjønes, Javier Benitez, Helge L Waldum

发表日期：2016

文献求助收藏

Skeletal effects of the saturated 3-thia Fatty Acid tetradecylthioacetic Acid in rats

饱和3-硫代脂肪酸十四烷基硫代乙酸对大鼠骨骼的影响

期刊:PPAR Research

影响因子:3.5

doi:10.1155/2011/436358

Astrid Kamilla Stunes, Irene Westbroek, Reidar Fossmark, Rolf Kristian Berge, Janne Elin Reseland, Unni Syversen

发表日期：2011

文献求助收藏

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

在卵巢切除大鼠中，过氧化物酶体增生激活受体 (PPAR) α 激动剂非诺贝特可维持骨量，而 PPAR γ 激动剂吡格列酮则加剧骨质流失

期刊:BMC Endocrine Disorders

影响因子:2.8

doi:10.1186/1472-6823-11-11

Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, Reidar Fossmark, Jan H Waarsing, Erik F Eriksen, Christiane Petzold, Janne E Reseland, Unni Syversen

发表日期：2011

文献求助收藏